Clinical significance of intratumor heterogeneity for gynecological carcinoma

Saved in:
Bibliographic Details
Published in:Chronic diseases and translational medicine 2015-03, Vol.1 (1), p.14-17
Main Authors: Yang, Ying-Chao, Li, Xiao-Ping
Format: Article
Language:English
Subjects:
Chemotherapy resistance
Diagnose
Follow-up
Intratumor heterogeneity
Tumor marker
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4294-5bfa0608c2562733f45c90ea2b592df19e37fddc4c20bd32cae2cff9788310d73
container_end_page 17
container_issue 1
container_start_page 14
container_title Chronic diseases and translational medicine
container_volume 1
creator Yang, Ying-Chao
Li, Xiao-Ping
description
doi_str_mv 10.1016/j.cdtm.2015.02.005
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a4acefd4ce354a3cb88e954adecd88f5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>W_7788746689907289884569504849534849484852</cqvip_id><els_id>S2095882X15000067</els_id><doaj_id>oai_doaj_org_article_a4acefd4ce354a3cb88e954adecd88f5</doaj_id><sourcerecordid>1955066464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4294-5bfa0608c2562733f45c90ea2b592df19e37fddc4c20bd32cae2cff9788310d73</originalsourceid><addsrcrecordid>eNqNUk1vEzEQXSEQrUL_AAeUI5ekXn_s2gIh0UBLpSIuRXCzvOPxxtGu3Xo3Rfn3eJsQ0QviYHs0nvf8Zp6L4nVJliUpq_PNEuzYLykpxZLQJSHiWXFKhVQLIkr-PMdEiYWU9OdJcTYMvpnSomaSvCxOqCIVVZKeFl9XnQ8eTDcffBu8y2EAnEc392FMZtz2Mc3XOGKKLQb0427ucqbdBYTYxfYRCiaBD7E3r4oXznQDnh3OWfH98vPt6svi5tvV9erjzQI4VXwhGmdIRSRQUdGaMccFKIKGNkJR60qFrHbWAgdKGssoGKTgnKqlZCWxNZsV13teG81G3yXfm7TT0Xj9mIip1SaNHjrUhhtAZzkgE9wwaKRElSOLYKV0InN92HPdbZseLeDUd_eE9OlN8GvdxgctKs7qWmaCtweCFO-3OIy69wNg15mAcTvoUglBqorn8llB96WQ4jAkdMdnSqInW_VGT7bqyVZNqM62ZtCbvwUeIX9MzAXv9gW_fIe7_6DUq0-37OKSEFpPmt7v0ZgNe_CY9AAe8yewPiGMeaL-3-pWh5bWMbT3PrRHAT90Ho-seVVJpUhNpZKSi0oJwiVXgk17XlJQ9huYXtvE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1955066464</pqid></control><display><type>article</type><title>Clinical significance of intratumor heterogeneity for gynecological carcinoma</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Yang, Ying-Chao ; Li, Xiao-Ping</creator><creatorcontrib>Yang, Ying-Chao ; Li, Xiao-Ping</creatorcontrib><identifier>ISSN: 2095-882X</identifier><identifier>ISSN: 2589-0514</identifier><identifier>EISSN: 2589-0514</identifier><identifier>DOI: 10.1016/j.cdtm.2015.02.005</identifier><identifier>PMID: 29062982</identifier><language>eng</language><publisher>China: Elsevier B.V</publisher><subject>Chemotherapy resistance ; Diagnose ; Follow-up ; Intratumor heterogeneity ; Tumor marker</subject><ispartof>Chronic diseases and translational medicine, 2015-03, Vol.1 (1), p.14-17</ispartof><rights>2015 Chinese Medical Association</rights><rights>2015 The Authors. Chronic Diseases and Translational Medicine published by John Wiley &amp; Sons, Ltd on behalf of Chinese Medical Association</rights><rights>2015 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2015 Chinese Medical Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4294-5bfa0608c2562733f45c90ea2b592df19e37fddc4c20bd32cae2cff9788310d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/72220X/72220X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643778/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643778/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,27903,27904,36992,46030,46454,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29062982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Ying-Chao</creatorcontrib><creatorcontrib>Li, Xiao-Ping</creatorcontrib><title>Clinical significance of intratumor heterogeneity for gynecological carcinoma</title><title>Chronic diseases and translational medicine</title><addtitle>Chronic Diseases and Translational Medicine</addtitle><subject>Chemotherapy resistance</subject><subject>Diagnose</subject><subject>Follow-up</subject><subject>Intratumor heterogeneity</subject><subject>Tumor marker</subject><issn>2095-882X</issn><issn>2589-0514</issn><issn>2589-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqNUk1vEzEQXSEQrUL_AAeUI5ekXn_s2gIh0UBLpSIuRXCzvOPxxtGu3Xo3Rfn3eJsQ0QviYHs0nvf8Zp6L4nVJliUpq_PNEuzYLykpxZLQJSHiWXFKhVQLIkr-PMdEiYWU9OdJcTYMvpnSomaSvCxOqCIVVZKeFl9XnQ8eTDcffBu8y2EAnEc392FMZtz2Mc3XOGKKLQb0427ucqbdBYTYxfYRCiaBD7E3r4oXznQDnh3OWfH98vPt6svi5tvV9erjzQI4VXwhGmdIRSRQUdGaMccFKIKGNkJR60qFrHbWAgdKGssoGKTgnKqlZCWxNZsV13teG81G3yXfm7TT0Xj9mIip1SaNHjrUhhtAZzkgE9wwaKRElSOLYKV0InN92HPdbZseLeDUd_eE9OlN8GvdxgctKs7qWmaCtweCFO-3OIy69wNg15mAcTvoUglBqorn8llB96WQ4jAkdMdnSqInW_VGT7bqyVZNqM62ZtCbvwUeIX9MzAXv9gW_fIe7_6DUq0-37OKSEFpPmt7v0ZgNe_CY9AAe8yewPiGMeaL-3-pWh5bWMbT3PrRHAT90Ho-seVVJpUhNpZKSi0oJwiVXgk17XlJQ9huYXtvE</recordid><startdate>201503</startdate><enddate>201503</enddate><creator>Yang, Ying-Chao</creator><creator>Li, Xiao-Ping</creator><general>Elsevier B.V</general><general>KeAi Publishing</general><general>Wiley</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>6I.</scope><scope>AAFTH</scope><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>201503</creationdate><title>Clinical significance of intratumor heterogeneity for gynecological carcinoma</title><author>Yang, Ying-Chao ; Li, Xiao-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4294-5bfa0608c2562733f45c90ea2b592df19e37fddc4c20bd32cae2cff9788310d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Chemotherapy resistance</topic><topic>Diagnose</topic><topic>Follow-up</topic><topic>Intratumor heterogeneity</topic><topic>Tumor marker</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Ying-Chao</creatorcontrib><creatorcontrib>Li, Xiao-Ping</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Wiley Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Chronic diseases and translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Ying-Chao</au><au>Li, Xiao-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of intratumor heterogeneity for gynecological carcinoma</atitle><jtitle>Chronic diseases and translational medicine</jtitle><addtitle>Chronic Diseases and Translational Medicine</addtitle><date>2015-03</date><risdate>2015</risdate><volume>1</volume><issue>1</issue><spage>14</spage><epage>17</epage><pages>14-17</pages><issn>2095-882X</issn><issn>2589-0514</issn><eissn>2589-0514</eissn><cop>China</cop><pub>Elsevier B.V</pub><pmid>29062982</pmid><doi>10.1016/j.cdtm.2015.02.005</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2095-882X
ispartof Chronic diseases and translational medicine, 2015-03, Vol.1 (1), p.14-17
issn 2095-882X
2589-0514
2589-0514
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a4acefd4ce354a3cb88e954adecd88f5
source Publicly Available Content Database; Wiley Open Access; PubMed Central
subjects Chemotherapy resistance
Diagnose
Follow-up
Intratumor heterogeneity
Tumor marker
title Clinical significance of intratumor heterogeneity for gynecological carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A33%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20intratumor%20heterogeneity%20for%20gynecological%20carcinoma&rft.jtitle=Chronic%20diseases%20and%20translational%20medicine&rft.au=Yang,%20Ying-Chao&rft.date=2015-03&rft.volume=1&rft.issue=1&rft.spage=14&rft.epage=17&rft.pages=14-17&rft.issn=2095-882X&rft.eissn=2589-0514&rft_id=info:doi/10.1016/j.cdtm.2015.02.005&rft_dat=%3Cproquest_doaj_%3E1955066464%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4294-5bfa0608c2562733f45c90ea2b592df19e37fddc4c20bd32cae2cff9788310d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1955066464&rft_id=info:pmid/29062982&rft_cqvip_id=W_7788746689907289884569504849534849484852&rfr_iscdi=true